. Author manuscript; available in PMC: 2009 Jun 1.

Published in final edited form as: J Oral Maxillofac Surg. 2008 Jun;66(6):1112–1124. doi: 10.1016/j.joms.2007.09.013

Table 2.

Age (at time of explantation) and Gender distribution (in percentage), and means and standard deviations (SD) for outcome measures by implant group

Implant Group	Age Mean (SD)	Gender Female Prevalence	Symptom Severity Index Mean (SD)	Jaw Function Questionnaire Mean (SD)
Proplast/Teflon® (PTE) N=7	50 (±13)	100% N=7	0.62 (0.24)	2.9 (2.6)
Silastic® (Si)^* N=3	48 (±8)	66.7% N=2	0.40 (0.14)	2.5 (3.5)

NOTE: SD: Standard deviation.

The Silastic® implant encompasses the temporary/spacer and permanent types.